34 min ago
Nuvilex Begins Preclinical Studies With Translational Drug...
Nuvilex, Inc. , a clinical-stage, international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, announced today that studies are underway at Translational Drug Development's facilities in Scottsdale, Arizona, to determine if Nuvilex's unique cancer treatment can slow the accumulation of fluid, known as ... (more)
Nuvilex Announces Publication of Combined Results of the Initial...
The title of the publication is "Encapsulated Cells Expressing a Chemotherapeutic Activating Enzyme Allow the Targeting of Subtoxic Chemotherapy and and Efficacious: Data from Two Clinical Trials in Pancreatic Cancer."
Nuvilex Provides Update on Status of Preclinical Studies at Translational Drug Development
With the arrival of the encapsulated cells, the preclinical studies are now slated to begin at TD2 the week of is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box .
Nuvilex Announces That Dr. Richard M. Hyslop Will Present at the ACS...
The theme for this year's meeting is "Chemistry and Global Stewardship". Dr. Hyslop has been involved in cancer research for 35 years and is leading a team of scientists from proprietary "Cell-in-a-Box " live cell encapsulation technology.
Nuvilex and Austrianova Announce Results of Clinical Trial in Dogs...
These results were published in the . Sixteen female dogs were enrolled in the clinical trial.
Nuvilex Provides Shareholder Update on Milestone Accomplishments
Dear Nuvilex Shareholders, First and foremost, on behalf of the entire Nuvilex Management Team we wish to thank you for your continued support.